Evidence map›Paper›PMID 25550927›Full record

ArticleInternational journal of clinical and experimental medicine2014

Trends in age-specific cerebrovascular disease in the European Union.

Hui Wang, Wei Sun, Yue Ji, Jing Shi, Qinkao Xuan, Xiuzhi Wang, Junjie Xiao, Xiangqing Kong

Abstract read
In one paragraph

Article in International journal of clinical and experimental medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. The cost-effectiveness of a uniform versus age-based threshold for one-off screening for prevention of cardiovascular disease.The European journal of health economics : HEPAC : health economics in prevention and care · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hui WangDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University Nanjing 210029, China.
Wei SunDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University Nanjing 210029, China.
Yue JiDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University Nanjing 210029, China.
Jing ShiDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University Nanjing 210029, China.
Qinkao XuanDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University Nanjing 210029, China.
Xiuzhi WangDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University Nanjing 210029, China.
Junjie XiaoDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University Nanjing 210029, China ; Regeneration Lab, School of Life Science, Shanghai University Shanghai 200444, China.
Xiangqing KongDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University Nanjing 210029, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although the mortality of cerebrovascular disease (CVD) has been steadily declined in the European Union (EU), CVD remains among the major causes of death in EU. As risk factors such asobesity and diabetes mellitus are increasing, the trends of European CVD mortality remains unknown. To understand the variation in CVD mortality of different EU countries, we studied the trends in CVD mortality in EU countries over the last three decades between males and females. Age- and sex-specific mortality rates between 1980 and 2011 were calculated by data from the WHO mortality database. Joinpoint software was used to calculate annual percentage changes and to characterize trends in mortality rates over time. Our study showed that between 1980 and 2011, CVD mortality significantly decreased in both men and women across all age groups. The specific mortality trends varied largely between EU countries. The plateau trend was observed in little regions at different age groups, however, the EU as a whole displayed declined trend CVD mortality. During the last three decades, CVD mortality decreased substantially in the entire population of EU. However, despite this overall decline in CVD mortality, several areas were identified as having no change in their CVD mortality rates at different period. The whole EU needs to establish strict prevention measures toreduce the incidence of CVD risk factors.

Indexed as

Cerebrovascular diseasemortalitytrends

Identifiers

PMID25550927
PMCPMC4276185

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.